09/14/2021
8:45 PM | CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2021
8:44 PM | CRISPR Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2021
1:47 PM | ARK Investment Management LLC (Filed by)
CRISPR Therapeutics (Subject)
| Form SC 13G/A
| |
09/03/2021
7:00 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2021
7:00 PM | CRISPR Therapeutics (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2021
11:28 AM | Capital International Investors (Filed by)
CRISPR Therapeutics (Subject)
| Form SC 13G/A
| |
08/06/2021
7:00 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2021
4:21 PM | Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2021
4:54 PM | CRISPR Therapeutics (Issuer)
Novak Rodger (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2021
4:44 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
06/15/2021
3:41 PM | Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2021
5:23 PM | Behbahani Ali (Reporting)
CRISPR Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2021
4:39 PM | CRISPR Therapeutics (Issuer)
Treco Douglas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2021
4:39 PM | CRISPR Therapeutics (Issuer)
High Katherine A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2021
4:38 PM | CRISPR Therapeutics (Issuer)
Greene John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2021
4:37 PM | CRISPR Therapeutics (Issuer)
George Simeon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2021
4:36 PM | Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2021
4:35 PM | CRISPR Therapeutics (Issuer)
Fleming Harold Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2021
4:32 PM | CRISPR Therapeutics (Issuer)
Fleming Harold Edward (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/11/2021
6:10 AM | CRISPR Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2021
4:34 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2021
8:16 AM | CRISPR Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2021
3:22 PM | CRISPR Therapeutics (Filer)
| Form DEFA14A
| |
04/27/2021
3:19 PM | CRISPR Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/20/2021
6:22 AM | CRISPR Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2021
3:18 PM | CRISPR Therapeutics (Filer)
| Form PRE 14A
| |
03/24/2021
5:00 PM | Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2021
4:50 PM | CRISPR Therapeutics (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2021
4:49 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2021
4:47 PM | CRISPR Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2021
4:43 PM | CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2021
4:41 PM | CRISPR Therapeutics (Issuer)
Ho Tony W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2021
4:37 PM | CRISPR Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
| Form 4/A
| |
03/09/2021
4:40 PM | CRISPR Therapeutics (Issuer)
Ho Tony W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2021
3:13 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2021
2:58 PM | Capital International Investors (Filed by)
CRISPR Therapeutics (Subject)
| Form SC 13G/A
| |
02/16/2021
6:33 AM | CRISPR Therapeutics (Subject)
Versant Ventures IV, LLC (Filed by)
| Form SC 13D/A
| |
02/05/2021
5:10 AM | CRISPR Therapeutics (Subject)
Sumitomo Mitsui Trust Holdings, Inc. (Filed by)
| Form SC 13G/A
| |
01/20/2021
5:11 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/20/2021
5:07 PM | CRISPR Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/20/2021
5:05 PM | CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2021
3:12 PM | CRISPR Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/15/2021
3:10 PM | CRISPR Therapeutics (Filer)
| Form 424B5
| |
01/04/2021
3:12 PM | CRISPR Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2020
3:02 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2020
6:12 PM | Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2020
6:14 PM | Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
| Form 4/A
| |
12/17/2020
8:06 AM | CRISPR Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/14/2020
6:11 PM | Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2020
3:05 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2020
7:16 AM | CRISPR Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2020
7:12 AM | CRISPR Therapeutics (Filer)
| Form 424B5
| |
12/10/2020
3:35 PM | CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2020
6:54 PM | Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2020
6:50 AM | CRISPR Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2020
3:32 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2020
3:26 PM | CRISPR Therapeutics (Issuer)
Novak Rodger (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2020
8:14 AM | CRISPR Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2020
4:30 PM | Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2020
7:08 AM | CRISPR Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/28/2020
7:03 AM | CRISPR Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/21/2020
7:58 AM | CRISPR Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/13/2020
3:44 PM | CRISPR Therapeutics (Issuer)
Novak Rodger (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/09/2020
12:51 PM | ARK Investment Management LLC (Filed by)
CRISPR Therapeutics (Subject)
| Form SC 13G
| |
10/06/2020
4:48 PM | CRISPR Therapeutics (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2020
4:45 PM | CRISPR Therapeutics (Issuer)
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2020
4:38 PM | CRISPR Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2020
4:34 PM | CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2020
4:32 PM | CRISPR Therapeutics (Issuer)
Ho Tony W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2020
5:09 PM | Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2020
7:10 PM | Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2020
4:05 PM | CRISPR Therapeutics (Subject)
Versant Venture Capital IV, L.P. (Filed by)
| Form SC 13D/A
| |
09/18/2020
3:30 PM | Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2020
7:00 PM | Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2020
8:49 PM | Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2020
10:04 AM | Capital International Investors (Filed by)
CRISPR Therapeutics (Subject)
| Form SC 13G
| |
09/10/2020
1:54 PM | Capital International Investors (Filed by)
CRISPR Therapeutics (Subject)
| Form SC 13G
| |
09/03/2020
8:21 PM | Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2020
3:46 PM | CRISPR Therapeutics (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2020
3:44 PM | CRISPR Therapeutics (Issuer)
Novak Rodger (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2020
3:42 PM | CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2020
3:11 PM | CRISPR Therapeutics (Issuer)
Novak Rodger (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2020
3:20 PM | CRISPR Therapeutics (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/27/2020
3:46 PM | CRISPR Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/27/2020
3:41 PM | CRISPR Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/27/2020
3:35 PM | CRISPR Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2020
4:26 PM | CRISPR Therapeutics (Subject)
GLAXOSMITHKLINE PLC (Filed by)
| Form SC 13D/A
| |
07/09/2020
3:00 PM | CRISPR Therapeutics (Issuer)
Novak Rodger (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2020
3:14 PM | CRISPR Therapeutics (Issuer)
Novak Rodger (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2020
4:12 PM | CRISPR Therapeutics (Filer)
| Form 424B5
| |
06/29/2020
3:24 PM | CRISPR Therapeutics (Filer)
| Form 424B5
| |
06/26/2020
3:33 PM | CRISPR Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2020
3:28 PM | CRISPR Therapeutics (Issuer)
Novak Rodger (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2020
6:02 PM | Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2020
4:58 PM | CRISPR Therapeutics (Issuer)
Ho Tony W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
6:49 PM | Behbahani Ali (Reporting)
CRISPR Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
3:45 PM | CRISPR Therapeutics (Issuer)
Treco Douglas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
3:42 PM | CRISPR Therapeutics (Issuer)
Treco Douglas A (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/15/2020
3:37 PM | CRISPR Therapeutics (Issuer)
High Katherine A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
3:33 PM | CRISPR Therapeutics (Issuer)
Greene John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
